97 related articles for article (PubMed ID: 1146929)
21. Tazarotene does not affect the pharmacokinetics and efficacy of a norethindrone/ethinylestradiol oral contraceptive.
Yu Z; Yu D; Walker PS; Tang-Liu DD
Clin Pharmacokinet; 2004; 43(10):673-84. PubMed ID: 15244497
[TBL] [Abstract][Full Text] [Related]
22. Temporal relationships between ovulation and defined changes in the concentration of plasma estradiol-17 beta, luteinizing hormone, follicle-stimulating hormone, and progesterone. I. Probit analysis. World Health Organization, Task Force on Methods for the Determination of the Fertile Period, Special Programme of Research, Development and Research Training in Human Reproduction.
Am J Obstet Gynecol; 1980 Oct; 138(4):383-90. PubMed ID: 6775535
[TBL] [Abstract][Full Text] [Related]
23. Tiapride-induced chronic hyperprolactinaemia: interference with the human menstrual cycle.
L'Hermite M; Michaux-Duchêne A; Robyn C
Acta Endocrinol (Copenh); 1979 Oct; 92(2):214-27. PubMed ID: 494989
[TBL] [Abstract][Full Text] [Related]
24. Abnormal follicle-stimulating hormone and luteinizing hormone patterns contrasting with normal estradiol and progesterone secretion in women with longstanding unexplained infertility.
Dmowski WP; Rezai P; Auletta FJ; Scommegna A
J Clin Endocrinol Metab; 1981 Jun; 52(6):1218-24. PubMed ID: 6785296
[TBL] [Abstract][Full Text] [Related]
25. [Doses-related effects of lynestrenol on ovulation (author's transl)].
Pizarro MA; Thomas K; Ferin J
Reproduccion; 1976; 3(3-4):193-205. PubMed ID: 802117
[TBL] [Abstract][Full Text] [Related]
26. Hypothalamus-pituitary-ovarian axis in cyclic rats lacking progesterone actions.
Sánchez-Criado JE; Galiot F; Bellido C; Gonzalez D; Tébar M
Biol Reprod; 1993 Apr; 48(4):916-25. PubMed ID: 8485257
[TBL] [Abstract][Full Text] [Related]
27. Hormonal content of plasma and endometrium of women taking oral contraceptives.
Porias H; Carranco-López A; Sojo-Aranda I; González-Martínez R; Cervantes C; Parra A; Cortés-Gallegos V
Obstet Gynecol; 1978 Dec; 52(6):703-7. PubMed ID: 733138
[TBL] [Abstract][Full Text] [Related]
28. LH, FSH, estradiol and progesterone levels after discontinuation of hormonal contraception.
Balogh A; Ditrói F; Lampé LG
Acta Univ Palacki Olomuc Fac Med; 1981; 101():95-101. PubMed ID: 6242699
[TBL] [Abstract][Full Text] [Related]
29. The effect of a single midcycle administration of 0.5 or 2.0 mg dienogest (17 alpha-cyanomethyl-17 beta-hydroxy-estra-4,9-dien-3-one) on pituitary and ovarian function--investigation for the use as a postcoital contraceptive.
Köhler G; Göretzlehner G; Rudolf K; Rüting M; Meissner J; Kunkel S; Schollberg K
Exp Clin Endocrinol; 1984 Dec; 84(3):299-304. PubMed ID: 6441728
[TBL] [Abstract][Full Text] [Related]
30. [Proceedings: Effect of 0,5 mg lynestrenol on the normal cycle].
Friedrich E; Keller E; Jaeger-Whitegiver ER; Schindler AE
Arch Gynakol; 1975 Nov; 219(1-4):607-8. PubMed ID: 1243508
[No Abstract] [Full Text] [Related]
31. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F
J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
[TBL] [Abstract][Full Text] [Related]
32. [The effect of NIH-LH on the ovary of immature rats under the influence of progesterone, norgestrel, and lynestrenol].
Uhlarik A
Experientia; 1972 Jan; 28(1):91-3. PubMed ID: 5062495
[No Abstract] [Full Text] [Related]
33. [Hypophyseal reaction state during oral contraceptiva (author's transl)].
Gitsch E; Schneider WH; Schmid R; Spona J
Wien Klin Wochenschr; 1981 Oct; 93(19):599-601. PubMed ID: 6798764
[TBL] [Abstract][Full Text] [Related]
34. Fourteen-day versus twenty-one-day regimens of intermittent intranasal luteinizing hormone-releasing hormone agonist combined with an oral progestogen as antiovulatory contraceptive approach.
Lemay A; Faure N
J Clin Endocrinol Metab; 1986 Dec; 63(6):1379-85. PubMed ID: 2946711
[TBL] [Abstract][Full Text] [Related]
35. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
[TBL] [Abstract][Full Text] [Related]
36. Influence of oral contraceptives on immediate postabortal pituitary-ovarian function.
Lähteenmäki P
Acta Obstet Gynecol Scand Suppl; 1978; 76():1-43. PubMed ID: 696249
[No Abstract] [Full Text] [Related]
37. Opioid regulation of pituitary gonadotropins and prolactin in women using oral contraceptives.
Snowden EU; Khan-Dawood FS; Dawood MY
Am J Obstet Gynecol; 1986 Feb; 154(2):440-4. PubMed ID: 3080893
[TBL] [Abstract][Full Text] [Related]
38. Progesterone effects on gonadotropin release in women pretreated with estradiol.
Chang RJ; Jaffe RB
J Clin Endocrinol Metab; 1978 Jul; 47(1):119-25. PubMed ID: 122395
[TBL] [Abstract][Full Text] [Related]
39. Urinary hormone excretion patterns during low-dose progestogen administration.
Varga L; Tamme E
J Int Med Res; 1975; 3(2):63-72. PubMed ID: 1140508
[TBL] [Abstract][Full Text] [Related]
40. The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women.
Sherman BM; West JH; Korenman SG
J Clin Endocrinol Metab; 1976 Apr; 42(4):629-36. PubMed ID: 1262439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
